Therapeutic Outcomes of Isatin and Its Derivatives against Multiple Diseases: Recent Developments in Drug Discovery

• Main Authors: Rameshwar S. Cheke, Vaishali M. Patil, Sandip D. Firke, Jaya P. Ambhore, Iqrar A. Ansari, Harun M. Patel, Sachin D. Shinde, Visweswara Rao Pasupuleti, Md Imtaiyaz Hassan, Mohd Adnan, Adel Kadri, Mejdi Snoussi
• Format: Article
• Language: English; English
• Published: Multidisciplinary Digital Publishing Institute 2022
• Subjects: RC254-282 Neoplasms. Tumors. Oncology Including cancer and carcinogens; RM300-666 Drugs and their actions
• Online Access: https://eprints.ums.edu.my/id/eprint/33760/1/Therapeutic%20Outcomes%20of%20Isatin%20and%20Its%20Derivatives%20against%20Multiple%20Diseases.pdf; https://eprints.ums.edu.my/id/eprint/33760/2/Therapeutic%20Outcomes%20of%20Isatin%20and%20Its%20Derivatives%20against%20Multiple%20Diseases1.pdf; https://eprints.ums.edu.my/id/eprint/33760/; https://www.mdpi.com/1424-8247/15/3/272; https://doi.org/10.3390/ph15030272

Isatin (1H indole 2, 3-dione) is a heterocyclic, endogenous lead molecule recognized in humans and different plants. The isatin nucleus and its derivatives are owed the attention of researchers due to their diverse pharmacological activities such as anticancer, anti-TB, antifungal, antimicrobial, an...